Christopher P. Lowe - 03 Mar 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Reporting relationship: Interim CEO, COO & CFO
Issuer ticker: QNCX
Reported as of: 03 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2022, 16:55:40 UTC
Prior SEC filing: 05 Jan 2022
Next SEC filing: 31 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe

Key filing fact

Christopher P. Lowe filed Form 4 for Cortexyme, Inc. (QNCX) on 04 Mar 2022.

Key facts

This page summarizes Christopher P. Lowe's Form 4 filing for Cortexyme, Inc. (QNCX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Mar 2022, 16:55.

Change

Previous filing in this sequence was filed on 05 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QNCX transaction

Common Stock

Award

Transaction value: $0
Shares: +175,000
Change %: +194%
Price: $0.000000
Shares after: 265,000
Date: 03 Mar 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents grant of Restricted Stock Units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in equal quarterly installments over two years, with 1/8th of the total number of shares subject to the RSU Award vesting on each quarterly anniversary of the date of grant.